Hypercholesterolemia: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett m (→Treatment) |
imported>Robert Badgett |
||
| Line 2: | Line 2: | ||
==Treatment== | ==Treatment== | ||
[[Statin]] therapy benefits about 1 of every 24 patients with [[diabetes]] who use the treatment for 5 years if they are similar to the patients in the [[meta-analysis]] by Kearney et al ([[ | [[Statin]] therapy benefits about 1 of every 24 patients with [[diabetes]] who use the treatment for 5 years if they are similar to the patients in the [[meta-analysis]] by Kearney et al ([[Number needed to treat]] is 24).<ref name="pmid18191683">{{cite journal |author=Kearney PM, Blackwell L, Collins R, ''et al'' |title=Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis |journal=Lancet |volume=371 |issue=9607 |pages=117–25 |year=2008 |pmid=18191683 |doi=10.1016/S0140-6736(08)60104-X}}</ref> | ||
==References== | ==References== | ||
Revision as of 00:31, 19 January 2008
Hypercolesterolemia is "a condition with abnormally high levels of cholesterol in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population."[1]
Treatment
Statin therapy benefits about 1 of every 24 patients with diabetes who use the treatment for 5 years if they are similar to the patients in the meta-analysis by Kearney et al (Number needed to treat is 24).[2]
References
- ↑ Anonymous. Hypercholesterolemia. National Library of Medicine. Retrieved on 2008-01-18.
- ↑ Kearney PM, Blackwell L, Collins R, et al (2008). "Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis". Lancet 371 (9607): 117–25. DOI:10.1016/S0140-6736(08)60104-X. PMID 18191683. Research Blogging.